IRVINE, Calif.--(BUSINESS WIRE)--eGene Inc. (OTCBB:EGEI), a leading biotechnology company and developer of a compact and automated digital genetic analyzer, announced today that the Company has received confirmation from the Taiwan Patent Office of its decision to grant a patent for the “Multi-channel bio-separation cartridge." This marks the Company’s ninth patent worldwide.
